Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-03 · accession 0001567619-22-006494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-07 | 2022-03-03 | ARQT | Burrows Scott L | CFO | A - Grant | $0.00 | +13.3K | 35.6K | +60% | $0 |
| DM | 2022-03-07 | 2022-03-04+ | ARQT | Burrows Scott L | CFO | S - Sale | $16.85 | -303 | 35.3K | -0.9% | -$5,104 |
| D | 2022-03-07 | 2022-03-03 | ARQT | Burrows Scott L | CFO | A - Grant | $0.00 | +35.3K | 35.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | A | A | 13,300 | $0.00 | 35,559 | D | — | — | (F1) Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 3 of each year, beginning March 3, 2023, subject to the Reporting Person's continued service to the Issuer. |
| 2 | Common | Common Stock | 2022-03-04 | S | D | 293 | $16.86 | 35,266 | D | — | — | (F3) The transaction was executed in multiple trades in prices ranging from $16.63 to $17.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-03-07 | S | D | 10 | $16.44 | 35,256 | D | — | — | (F4) The transaction was executed in multiple trades in prices ranging from $16.44 to $16.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F5) Includes 17,400 RSUs. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-03-03 | A | A | 35,300 | $0.00 | 35,300 | D | $17.67 · — to 2032-03-03 | 35,300 Common Stock | (F6) 1/48th of the shares subject to the option vest on each monthly anniversary measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer. |